<records>
<record>
<language>eng</language>
<publisher>Excellent Publishers</publisher>
<journalTitle>
International Journal of Current Microbiology and Applied Sciences (IJCMAS) CODEN(USA)-IJCMO9
</journalTitle>
<issn>2319-7692</issn>
<eissn>2319-7706</eissn>
<publicationDate>2015-01-10</publicationDate>
<volume>5</volume>
<issue>1</issue>
<startPage>231</startPage>
<endPage>234</endPage>
<documentType>article</documentType>
<title language="eng">
Bacteriophages as an Antibacterial Agent: A Promising Alternative 
</title>

<authors>
<author>
<name> .	Kanupriya Dubey</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Sachin Chandraker</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name> Shweta Sao</name>
<affiliationId>3</affiliationId>
</author>
<author>
<name>Anjay Gupta</name>
<affiliationId>4</affiliationId>
</author>
<author>
<name>  Sumit Kumar Dubey</name>
<affiliationId>5</affiliationId>
</author>

</authors>

<affiliationsList>
<affiliationName affiliationId="1">
Intermediate Reference Laboratory, Raipur, India
</affiliationName>
<affiliationName affiliationId="2">
Dr. C. V. Raman University, Bilaspur C.G, India
</affiliationName>

<affiliationName affiliationId="3">
NIT Raipur, India
</affiliationName>

</affiliationsList>

<abstract language="eng">
<p>
Presently, the treatment of antibiotic resistant pathogenic bacteria has been
extensively performed worldwide. The evolution of pathogenic bacteria
against commercially available antimicrobial agents has become a critical
problem in modern era. Phage therapy could be used as a potential
alternative to antibiotics. Soviet Union used bacteriophages to treat infected
soldiers during Second World War. Afterwards the Russian researchers
started to work on the development of treatment via different
Bacteriophages and further US researcher was actively involved on phase
therapy and approached towards commercialization of phase therapy. Naturally occurring antibacterial agents are not able to overcome bacterial
resistance, while Bacteriophages have a higher mutation and replication rate,
so they can compete over the development of resistance of bacteria against
antimicrobial agents.
</p>
</abstract>

<fullTextUrl format="pdf">
http://www.ijcmas.com/vol-5-1/Kanupriya%20Dubey,%20et%20al.pdf
</fullTextUrl>
<keywords language="eng">
<keyword>Bacteriophages
</keyword>
</keywords>
<keywords language="eng">
<keyword>  Antibacterial
Agent</keyword>
</keywords>
<keywords language="eng">
<keyword>pathogenic
bacteria
</keyword>
</keywords>


</record>
</records>